Search

Your search keyword '"Mazur, W"' showing total 534 results
Start Over Author "Mazur, W"
534 results on '"Mazur, W"'

1. Association between sternal wound complications and 10-year mortality following coronary artery bypass grafting

Author

Taggart, D., Ratnatunga, Westaby, S., Cook, J., Wallis, C., Wos, S., Jasinski, M., Deja, M., Widenka, K., Blach, A., Gocol, R., Hudziak, D., Zurek, P., Bachowski, R., Mrozek, R., Kargul, T., Domarardzki, W., Frackiewicz, J., Zamvar, V., Ezakadan, D., Buxton, B., Seevanayagam, S., Matalanis, G., Rosalion, A., Negri, J., Moten, S., Atkinson, V., Newcomb, A., Polidano, P., Pana, R., Gerbo, S., O'Keefe, P., von Oppell, U., Mehta, D., Azzu, A., Szafranek, A., Kulatilake, E., Evans, J., Martin, N., Banner, D., Trivedi, U., Forsyth, A., Hyde, J., Cohen, A., Lewis, M., Gardner, E., MacKenzie, A., Cooter, N., Joyce, E., Parker, J., Champney, F., Clark, S., Dark, J., Tocewicz, K., Pillay, T., Rowling, S., Adams-Hall, J., Bochenek, A., Cisowski, M., Bolkowski, M., Morawski, W., Guc, M., Krejca, M., Wilczynski, M., Duralek, A., Gerber, W., Skarysz, J., Shrestha, R., Swiech, W., Szmagala, X., Krzych, L., Pawlak, A., Kepa, K., Hasan, R., Keenan, D., Prendergast, B., Odom, N., McLaughlin, K., Cummings-Fosong, G., Mathew, C., Iles-Smith, H., Oomen, A., Desai, J., El-Gamel, A., John, L., Wendler, O., Andrews, M., Rance, K., Williams, R., Hogervorst, V., Gregory, J., Jessup, J., Knighton, A., Hoare, A., Ritchie, A., Choong, C., Nair, S., Sudarshan, C., Jenkins, D., Large, S., Barman, M., Dhital, K., Routledge, T., Rosengard, B., Munday, H., Rintoul, K., Jarrett, E., Lao-Sirieix, S., Wilkinson, A., Garner, L., Osmond, J., Holcombe, H., Cale, A., Griffin, S., Dickson, J., Spyt, T., Gershlick, A., Hickey, M., Sosnowski, A., Peek, G., Szostek, J., Hadjinikalaou, L., Logtens, E., Oakley, M., Leji, S., Gaer, J., Amrani, M., Dreyfus, G., Bahrami, T., de Robertis, F., Baig, K., Asimakopoulos, G., Vohra, H., Pai, V., Tadjkarimi, S., Soleimani, G., Stavri, G., Bull, H., Collappen, H., Sadowksi, J., Kapelak, B., Gaweda, B., Rudzinski, P., Stolinski, J., Konstanty-Kalandyk, J., Moraes, F., Moraes, C., Wanderley, J., Pepper, J., De Souza, A., Petrou, M., Trimlett, R., Morgan, T., Gavino, J., Wang, S.F., Chandrasekaran, V., Kanagasaby, R., Sarsam, M., Ryan, H., Billings, L., Ruddick, L., Achampong, A., Forster, E., Mohama, E., McDonnell, P., Pawlaczyk, R., Siondalski, P., Rogowski, J., Roszak, K., Jarmoszewicz, K., Jagielak, D., Gafka, S., Mannam, G., Naguboyin, Sajja, L. Rao, Dandu, B., Peddireddy, J., Adepu, A., Briffa, N., Braidley, P., Cooper, G., Allen, K., Sangha, G., Bridge, C., McMellon, H., Shaw, P., Casabona, R., Dato, G. Actis, Bardi, G., Del Ponte, S., Forsennati, F., Parisi, F., Punta, G., Flocco, R., Sansone, F., Zingarelli, E., Demartino, A., Dihmis, W., Kuduvali, M., Prince, C., Rogers, H., McQuade, L., Duran-Rosas, A., Anisimowicz, L., Bokszanski, M., Pawliszak, W., Kolakowski, J., Lau, G., Ogorzeja, W., Gumanska, I., Kulinski, P., Podesser, B., Trescher, K., Bernecker, O., Holzinger, C., Binder, K., Schor, I., Bergmann, P., Kassal, H., Dunkel, E., Motovova, B., Trehan, N., Meharwal, Z., Malhotra, R., Goel, M., Kumer, B., Bazaz, S., Bake, N., Singh, A., Mishka, Y., Gupta, R., Basumatary, S., Zembala, M., Szafron, B., Pacholewicz, J., Krason, M., Farmas, Wojarski, Zych, Szymanik, I., Kolwca, M., Mazur, W., Kurowicki, A., Zurek, S., Stacel, T., Jaworska, I., Gaudino, Mario, Audisio, Katia, Rahouma, Mohamed, Robinson, N. Bryce, Soletti, Giovanni J., Cancelli, Gianmarco, Masterson Creber, Ruth M., Gray, Alastair, Lees, Belinda, Gerry, Stephen, Benedetto, Umberto, Flather, Marcus, and Taggart, David P.

Published
2023
Full Text
View/download PDF

2. Sputum Vitamin D Binding Protein (VDBP) GC1S/1S Genotype Predicts Airway Obstruction: A Prospective Study in Smokers with COPD

Author

Gao J, Törölä T, Li CX, Ohlmeier S, Toljamo T, Nieminen P, Hattori N, Pulkkinen V, Iwamoto H, and Mazur W

Subjects
vitamin d binding protein (vdbp), genotype, copd, prospective study, sputum, Diseases of the respiratory system, RC705-779
Abstract

Jing Gao,1,* Tanja Törölä,1,* Chuan-Xing Li,2 Steffen Ohlmeier,3 Tuula Toljamo,4 Pentti Nieminen,5 Noboru Hattori,6 Ville Pulkkinen,1 Hiroshi Iwamoto,6 Witold Mazur1 1Heart and Lung Centre, Department of Pulmonary Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; 2Pulmonomics Group, Respiratory Medicine Unit, Department of Medicine & Centre for Molecular Medicine, Karolinska Institute, Stockholm, Sweden; 3Proteomics Core Facility, Biocentre Oulu, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland; 4Department of Pulmonary Medicine, Lapland Central Hospital, Rovaniemi, Finland; 5Medical Informatics and Statistics Group, University of Oulu, Oulu, Finland; 6Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan*These authors contributed equally to this workCorrespondence: Jing GaoHeart and Lung Centre, Department of Pulmonary Medicine, University of Helsinki and Helsinki University Hospital, FinlandTel +358417071559Email jing.gao@helsinki.fi, HelsinkiIntroduction: The vitamin D binding protein (VDBP, also known as GC-globulin) and vitamin D deficiency have been associated with chronic obstructive pulmonary disease (COPD). rs7041 and rs4588 are two single nucleotide polymorphisms of the VDBP gene, including three common allelic variants (GC1S, GC1F and GC2). Previous studies primarily assessed the serum levels of vitamin D and VDBP in COPD. However, less is known regarding the impact of the local release of VDBP on COPD lung function. Thus, we examined the association of sputum and plasma VDBP with lung function at baseline and at four years, and examined potential genetic polymorphism interactions.Methods: The baseline levels of sputum VDBP, plasma VDBP and plasma 25-OH vitamin D, as well as the GC rs4588 and rs7041 genotypes, were assessed in a 4-year Finnish follow-up cohort (n = 233) of non-smokers, and smokers with and without COPD. The associations between the VDBP levels and the longitudinal decline of lung function were further analysed.Results: High frequencies of the haplotypes in rs7041/rs4588 were homozygous GC1S/1S (42.5%). Higher sputum VDBP levels in stage I and stage II COPD were observed only in carriers with GC1S/1S genotype when compared with non-smokers (p = 0.034 and p = 0.002, respectively). Genotype multivariate regression analysis indicated that the baseline sputum VDBP and FEV1/FVC ratio at baseline independently predicted FEV1% at follow-up.Discussion and Conclusion: The baseline sputum VDBP expression was elevated in smokers with COPD among individuals with the GC1S/1S genotype, and predicted follow-up airway obstruction. Our results suggest that the GC polymorphism should be considered when exploring the potential of VDBP as a biomarker for COPD.Keywords: vitamin D binding protein, VDBP, genotype, COPD, prospective study, sputum

Published
2020

3. Incidence and clinical implications of intraoperative bilateral internal thoracic artery graft conversion: Insights from the Arterial Revascularization Trial

Author

Ratnatunga, C., Westaby, S., Cook, J., Wallis, C., Wos, S., Jasinski, M., Widenka, K., Blach, A., Gocol, R., Hudziak, D., Zurek, P., Deja, M., Bachowski, R., Mrozek, R., Kargul, T., Domarardzki, W., Frackiewicz, J., Zamvar, V., Ezakadan, D., Buxton, B., Seevanayagam, S., Matalanis, G., Rosalion, A., Negri, J., Moten, S., Atkinson, V., Newcomb, A., Polidano, P., Pana, R., Gerbo, S., O'Keefe, P., von Oppell, U., Mehta, D., Azzu, A., Szafranek, A., Kulatilake, E., Evans, J., Martin, N., Banner, D., Trivedi, U., Forsyth, A., Hyde, J., Cohen, A., Lewis, M., Gardner, E., MacKenzie, A., Cooter, N., Joyce, E., Parker, J., Champney, F., Clark, S., Dark, J., Tocewicz, K., Pillay, T., Rowling, S., Adams-Hall, J., Bochenek, A., Cisowski, M., Bolkowski, M., Morawski, W., Guc, M., Krejca, M., Wilczynski, M., Duralek, A., Gerber, W., Skarysz, J., Shrestha, R., Swiech, W., Szmagala, P., Krzych, L., Pawlak, A., Kepa, K., Hasan, R., Keenan, D., Prendergast, B., Odom, N., McLaughlin, K., Cummings-Fosong, G., Mathew, C., Iles-Smith, H., Oomen, A., Desai, J., El-Gamel, A., John, L., Wendler, O., Andrews, M., Rance, K., Williams, R., Hogervorst, V., Gregory, J., Jessup, J., Knighton, A., Hoare, A., Ritchie, A., Choong, C., Nair, S., Jenkins, D., Large, S., Sudarshan, C., Barman, M., Dhital, K., Routledge, T., Rosengard, B., Munday, H., Rintoul, K., Jarrett, E., Lao-Sirieix, S., Wilkinson, A., Garner, L., Osmond, J., Holcombe, H., Cale, A., Griffin, S., Dickson, J., Spyt, T., Hickey, M., Sosnowski, A., Peek, G., Szostek, J., Hadjinikalaou, L., Logtens, E., Oakley, M., Leji, S., Gaer, J., Amrani, M., Dreyfus, G., Bahrami, T., de Robertis, F., Baig, K., Asimakopoulos, G., Vohra, H., Pai, V., Tadjkarimi, S., Soleimani, B., Stavri, G., Bull, G., Collappen, H., Sadowksi, J., Gaweda, B., Rudzinski, P., Stolinski, J., Konstanty-Kalandyk, J., Moraes, F., Moraes, C., Wanderley, J., Pepper, J., De Souza, A., Petrou, M., Trimlett, R., Morgan, T., Gavino, J., Wang, S.F., Chandrasekaran, V., Kanagasaby, R., Sarsam, M., Ryan, H., Billings, L., Ruddick, L., Achampong, A., Forster, E., Pawlaczyk, R., Siondalski, P., Rogowski, J., Roszak, K., Jarmoszewicz, K., Jagielak, D., Gafka, S., Mannam, G., Naguboyin, G., Rao Sajja, L., Dandu, B., Briffa, N., Braidley, P., Cooper, G., Allen, K., Sangha, G., Bridge, C., McMellon, H., Casabona, R., Actis Dato, G., Bardi, G., Del Ponte, S., Forsennati, P., Parisi, F., Punta, G., Flocco, R., Sansone, F., Zingarelli, E., Dihmis, W., Kuduvali, M., Prince, C., Rogers, H., McQuade, L., Anisimowicz, L., Bokszanski, M., Pawliszak, W., Kolakowski, J., Lau, G., Ogorzeja, W., Gumanska, I., Kulinski, P., Podesser, B., Trescher, K., Bernecker, O., Holzinger, C., Binder, K., Schor, I., Bergmann, P., Kassal, H., Motovova, B., Trehan, N., Meharwal, Z., Malhotra, R., Goel, M., Kumer, B., Bazaz, S., Bake, N., Singh, A., Mishka, Y., Gupta, R., Basumatary, S., Zembala, M., Szafron, B., Pacholewicz, J., Krason, M., Farmas, A., Wojarski, J., Zych, B., Szymanik, I., Kolwca, M., Mazur, W., Kurowicki, A., Zurek, S., Stacel, T., Jaworska, I., Sleight, P., Channon, K., Farrell, B., Stables, R., Vermes, G., Pearson, J., Pitman, M., Yusuf, S., Pocock, S., Julian, D., Treasure, T., Von Oppel, U., Kanagasabay, R., Collinson, J., Bakhai, A., O'Hanlon, R., Kotecha, D., Qureshi, K., Geisler, T., Manzano-Espinosa, L., Benedetto, Umberto, Altman, Douglas G., Flather, Marcus, Gerry, Stephen, Gray, Alastair, Lees, Belinda, and Taggart, David P.

Published
2018
Full Text
View/download PDF

5. Characterization of sputum biomarkers for asthma–COPD overlap syndrome

Author

Gao J, Iwamoto H, Koskela J, Alenius H, Hattori N, Kohno N, Laitinen T, Mazur W, and Pulkkinen V

Subjects
COPD pathology, asthma, ACOS., Diseases of the respiratory system, RC705-779
Abstract

Jing Gao,1 Hiroshi Iwamoto,2 Jukka Koskela,3 Harri Alenius,4 Noboru Hattori,2 Nobuoki Kohno,5 Tarja Laitinen,6 Witold Mazur,1 Ville Pulkkinen1 1Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; 2Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan; 3Clinical Research Unit of Pulmonary Diseases and Division of Pulmonology, Heart and Lung Center, University of Helsinki and Helsinki University Hospital, 4Unit of Systems Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland; 5Hiroshima Cosmopolitan University, Hiroshima, Japan; 6Department of Pulmonary Diseases and Clinical Allergology, Turku University Hospital, University of Turku, Turku, Finland Abstract: Asthma–COPD overlap syndrome (ACOS) is a commonly encountered chronic airway disease. However, ACOS is still a consensus-based clinical phenotype and the underlying inflammatory mechanisms are inadequately characterized. To clarify the inflammatory mediatypical for ACOS, five biomarkers, namely interleukin (IL)-13, myeloperoxidase (MPO), neutrophil gelatinase-associated lipocalin (NGAL), chitinase-like protein (YKL-40), and IL-6, were selected. This study hypothesized that sputum biomarkers relevant for airway inflammation in asthma (IL-13), COPD (MPO, NGAL), or in both asthma and COPD (YKL-40, IL-6) could be used to differentiate ACOS from COPD and asthma. The aim of this study was to characterize the inflammatory profile and improve the recognition of ACOS. Induced sputum levels of IL-13, MPO, NGAL, YKL-40, and IL-6 were measured by enzyme-linked immunosorbent assay/Luminex assay in a Finnish discovery cohort (n=90) of nonsmokers, smokers, and patients with asthma, COPD, and ACOS and validated in a Japanese cohort (n=135). The classification accuracy of potential biomarkers was compared with area under the receiver operating characteristic curves. Only sputum NGAL levels could differentiate ACOS from asthma (P

Published
2016

8. Characterization of sputum biomarkers for asthma–COPD overlap syndrome [Erratum]

Author

Gao J, Iwamoto H, Koskela J, Alenius H, Hattori N, Kohno N, Laitinen T, Mazur W, and Pulkkinen V

Subjects
Diseases of the respiratory system, RC705-779
Abstract

Gao J, Iwamoto H, Koskela J, et al. International Journal of Chronic Obstructive Pulmonary Disease. 2016;11: 2457–2465. On page 2457, Abstract, line 3, the text “To clarify the inflammatory mediatypical for ACOS, five biomarkers, namely interleukin (IL)-13, myeloperoxidase (MPO), neutrophil gelatinase-associated lipocalin (NGAL), chitinase-like protein (YKL-40), and IL-6, were selected” should be “To clarify the inflammatory mediators typical for ACOS, five biomarkers, namely interleukin (IL)-13, myeloperoxidase (MPO), neutrophil gelatinase-associated lipocalin (NGAL), chitinase-like protein (YKL-40), and IL-6, were selected.” Read the original article

Published
2017

10. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)

Author

Zeuzem, S., Flisiak, R., Vierling, J. M., Mazur, W., Mazzella, G., Thongsawat, S., Abdurakhmanov, D., Van Kính, N., Calistru, P., Heo, J., Stanciu, C., Gould, M., Makara, M., Hsu, S.-J., Buggisch, P., Samuel, D., Mutimer, D., Nault, B., Merz, M., Bao, W., Griffel, L. H., Brass, C., Naoumov, N. V., Tanno, Hugo, Bessone, Fernando, Terg, Ruben, Frider, Bernardo, Bertuzzi, Romina, Desmond, Paul, Zekry, Amany, Weltman, Martin, George, Jacob, Crawford, Darrell, Matthews, Gail, Moreno, Christophe, Van Vlierberghe, Hans, Reynaert, Hendrik, Gould, Michael, Lee, Samuel, Ramji, Alnoor, Tam, Edward, Marotta, Paul, Yoshida, Eric, Wong, Florence, Feld, Jordan, Samuel, Didier, Marcellin, Patrick, Alric, Laurent, Zarski, Jean-Pierre, Zoulim, Fabien, Buggisch, Peter, Hinrichsen, Holger, Goeser, Tobias, Zeuzem, Stefan, Galle, Peter, Berg, Thomas, Schott, Eckart, Rasenack, Jens, Gerken, Guido, Wedemeyer, Hans, Tsang, Owen, Yuen, Man-Fung, Chan, Henry, Hui, Aric Josun, Makara, Mihaly, Tornai, Istvan, Gervain, Judit, Szalay, Ferenc, Varga, Marta, Horvath, Gabor, Hunyady, Bela, Vincze, Aron, Mazzella, Giuseppe, Gaeta, Giovanni Battista, Alberti, Alfredo, Colombo, Massimo, Andreone, Pietro, Rizzetto, Mario, Angelico, Mario, Craxi, Antonio, Picciotto, Antonino, Sacchi, Paolo, Vinci, Maria, Invernizzi, Pietro, Bruno, Savino, Heo, Jeong, Lee, Younjae, Cho, Mong, Han, Sangyoung, Lee, Jinwoo, Ahn, Sanghoon, Lim, Youngsuk, Hwang, Seonggyu, Sanchez, Juan, Muñoz, Linda, Maldonado, Hector, Mazur, Wlodzimierz, Flisiak, Robert, Jablkowski, Maciej, Kryczka, Wieslaw, Halota, Waldemar, Calistru, Petre, Prelipcean, Cristina, Musa, Manuela, Stanciu, Carol, Manuc, Mircea, Tanasescu, Coman, Dumitrascu, Dan, Abdurakhmanov, Djamal, Chulanov, Vladimir, Nikitin, Igor, Zhdanov, Konstantin, Esaulenko, Elena, Maevskaya, Marina, Znoyko, Olga, Lamoglia, Ricard Sola, Ferret, Maria Buti, Garcia-Samaniego, Javier, Gomez, Manuel Romero, Diago, Moises, Calleja, Jose Luis, Hsu, Shih-Jer, Chuang, Wan-Long, Hu, Tsung-Hui, Peng, Cheng-Yuan, Chen, Chi-Yi, Kao, Jia-Horng, Thongsawat, Satawat, Sukeepaisarnjaroen, Wattana, Piratvisuth, Teerha, Tanwandee, Tawesak, Komolmit, Piyawat, Agarwal, Kosh, Mutimer, David, Brown, Ashley, Foster, Graham, McPherson, Stuart, Ryder, Stephen, Poulos, John, Rustgi, Vinod, Lyche, Kip, Omarro, Steven, Vierling, John, Ghalib, Reem, Karnam, Umaprasanna, Peine, Craig, Galati, Joseph, Person, John, De La Torre, Andrew, Ravendhran, Natarajan, Mushahwar, Andria, OʼLeary, Jacqueline, Lee, William, Lawitz, Eric, Ankoma-Sey, Victor, King, John, Pound, David, Scarsella, Anthony, Thuluvath, Paul, Pockros, Paul, Mailliard, Mark, Shiffman, Mitchell, Sylvestre, Diana, Heiman, David, Jacobson, Ira, Bacon, Bruce, Dimitroff, James, Reindollar, Robert, Tobias, Hillel, Godofsky, Eliot, Rodriguez-Torres, Maribel, Bennett, Michael, Ben-Zvi, Jeffrey, Van, Kinh Nguyen, Dao, Long, Huu, Hoang Bui, Minh, Yen Lam, Le Thanh, Ly, and Van Long, Dao

Published
2015
Full Text
View/download PDF

14. Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery

Author

Benedetto, Umberto, primary, Gaudino, Mario F., additional, Dimagli, Arnaldo, additional, Gerry, Stephen, additional, Gray, Alastair, additional, Lees, Belinda, additional, Flather, Marcus, additional, Taggart, David P., additional, Westaby, S., additional, Cook, J., additional, Wallis, C., additional, Wos, S., additional, Jasinski, M., additional, Widenka, K., additional, Blach, A., additional, Gocol, R., additional, Hudziak, D., additional, Zurek, P., additional, Deja, M., additional, Bachowski, R., additional, Mrozek, R., additional, Kargul, T., additional, Domarardzki, W., additional, Frackiewicz, J., additional, Zamvar, V., additional, Ezakadan, D., additional, Buxton, B., additional, Seevanayagam, S., additional, Matalanis, G., additional, Rosalion, A., additional, Negri, J., additional, Moten, S., additional, Atkinson, V., additional, Newcomb, A., additional, Polidano, P., additional, Pana, R., additional, Gerbo, S., additional, O’Keefe, P., additional, von Oppell, U., additional, Mehta, D., additional, Azzu, A., additional, Szafranek, A., additional, Kulatilake, E., additional, Evans, J., additional, Martin, N., additional, Banner, D., additional, Trivedi, U., additional, Forsyth, A., additional, Hyde, J., additional, Cohen, A., additional, Lewis, M., additional, Gardner, E., additional, MacKenzie, A., additional, Cooter, N., additional, Joyce, E., additional, Parker, J., additional, Champney, F., additional, Clark, S., additional, Dark, J., additional, Tocewicz, K., additional, Pillay, T., additional, Rowling, S., additional, Adams-Hall, J., additional, Bochenek, A., additional, Cisowski, M., additional, Bolkowski, M., additional, Morawski, W., additional, Guc, M., additional, Krejca, M., additional, Wilczynski, M., additional, Duralek, A., additional, Gerber, W., additional, Skarysz, J., additional, Shrestha, R., additional, Swiech, W., additional, Szmagala, P., additional, Krzych, L., additional, Pawlak, A., additional, Kepa, K., additional, Hasan, R., additional, Keenan, D., additional, Prendergast, B., additional, Odom, N., additional, McLaughlin, K., additional, Cummings-Fosong, G., additional, Mathew, C., additional, Iles-Smith, H., additional, Oomen, A., additional, Desai, J., additional, El-Gamel, A., additional, John, L., additional, Wendler, O., additional, Andrews, M., additional, Rance, K., additional, Williams, R., additional, Hogervorst, V., additional, Gregory, J., additional, Jessup, J., additional, Knighton, A., additional, Hoare, A., additional, Ritchie, A., additional, Choong, C., additional, Nair, S., additional, Jenkins, D., additional, Large, S., additional, Sudarshan, C., additional, Barman, M., additional, Dhital, K., additional, Routledge, T., additional, Rosengard, B., additional, Munday, H., additional, Rintoul, K., additional, Jarrett, E., additional, Lao-Sirieix, S., additional, Wilkinson, A., additional, Garner, L., additional, Osmond, J., additional, Holcombe, H., additional, Cale, A., additional, Griffin, S., additional, Dickson, J., additional, Spyt, T., additional, Hickey, M., additional, Sosnowski, A., additional, Peek, G., additional, Szostek, J., additional, Hadjinikalaou, L., additional, Logtens, E., additional, Oakley, M., additional, Leji, S., additional, Gaer, J., additional, Amrani, M., additional, Dreyfus, G., additional, Bahrami, T., additional, Baig, K., additional, Asimakopoulos, G., additional, Vohra, H., additional, Pai, V., additional, Tadjkarimi, Soleimani, S., additional, Stavri, G., additional, Bull, G., additional, Collappen, H., additional, Sadowksi, J., additional, Gaweda, B., additional, Rudzinski, P., additional, Stolinski, J., additional, Konstanty-Kalandyk, J., additional, Moraes, F., additional, Moraes, C., additional, Wanderley, J., additional, Pepper, J., additional, De Souza, A., additional, Petrou, M., additional, Trimlett, R., additional, Morgan, T., additional, Gavino, J., additional, Wang, S.F., additional, Chandrasekaran, V., additional, Kanagasaby, R., additional, Sarsam, M., additional, Ryan, H., additional, Billings, L., additional, Ruddick, L., additional, Achampong, A., additional, Forster, E., additional, Pawlaczyk, R., additional, Siondalski, P., additional, Rogowski, J., additional, Roszak, K., additional, Jarmoszewicz, K., additional, Jagielak, D., additional, Gafka, S., additional, Mannam, Naguboyin, G., additional, Rao Sajja, L., additional, Dandu, B., additional, Briffa, N., additional, Braidley, P., additional, Cooper, G., additional, Allen, K., additional, Sangha, G., additional, Bridge, C., additional, McMellon, H., additional, Casabona, R., additional, Actis Dato, G., additional, Bardi, G., additional, Del Ponte, Forsennati, S., additional, Parisi, F., additional, Punta, G., additional, Flocco, R., additional, Sansone, F., additional, Zingarelli, E., additional, Dihmis, W., additional, Kuduvali, M., additional, Rince, C., additional, Rogers, H., additional, McQuade, L., additional, Anisimowicz, L., additional, Bokszanski, M., additional, Pawliszak, W., additional, Kolakowski, J., additional, Lau, G., additional, Ogorzeja, W., additional, Gumanska, I., additional, Kulinski, P., additional, Podesser, B., additional, Trescher, K., additional, Bernecker, O., additional, Holzinger, C., additional, Binder, K., additional, Schor, I., additional, Bergmann, P., additional, Kassal, H., additional, Motovova, B., additional, Trehan, N., additional, Meharwal, Z., additional, Malhotra, R., additional, Goel, M., additional, Kumer, B., additional, Bazaz, S., additional, Bake, N., additional, Singh, A., additional, Mishka, Y., additional, Gupta, R., additional, Basumatary, S., additional, Zembala, M., additional, Szafron, B., additional, Pacholewicz, J., additional, Krason, M., additional, Szymanik, I., additional, Kolwca, M., additional, Mazur, W., additional, Kurowicki, A., additional, Zurek, S., additional, Stacel, T., additional, and Jaworska, I., additional

Published
2020
Full Text
View/download PDF

16. Prospects and Challenges for the Spatial Quantification of the Diffusion of Fluids Containing 1H in the Pore System of Rock Cores.

Author

Krzyżak, A. T., Mazur, W., Fheed, A., and Węglarz, W. P.

Subjects
*DIFFUSION tensor imaging, *NUCLEAR magnetic resonance, *PORE size distribution, *MAGNETIC resonance imaging, *DIFFUSION magnetic resonance imaging, *DRILL core analysis, *TORTUOSITY, *ELLIPSOIDS
Abstract

Nuclear magnetic resonance (MR) (NMR) is commonly used for the determination of rock porosity, as well as pore size distribution (PSD) and tortuosity, required to handle hydrocarbon exploitation. Emerging technologies for NMR equipment now enable the visualization of porosity using magnetic resonance imaging (MRI). Currently, single‐point imaging is the most common MRI technique employed, but diffusion‐weighted imaging has been attracting the attention of geologists and geophysicists. In this study, a more advanced technique, diffusion tensor imaging (DTI), is proposed for the characterization of rock core samples. The main purpose of this paper is to demonstrate the usefulness of DTI in the petrophysical characterization of rocks and discuss its strengths. As an example, a carbonate core sample was examined using DTI. The diffusion tensor (DT) was obtained and DT parameters (mean diffusivity, MD; fractional anisotropy, FA; three eigenvalues; DT components; and proton density, PD) were visualized in 2D and 3D. Each parameter was described and its utility in terms of pore space characterization was analyzed. In addition, a new parameter, principal diffusion tracts, was introduced based on the DT tractography performed in the study. The analysis is summarized in a set of DT parameters and a resultant ellipsoid that delivers complementary information about the sample's pore network microgeometry, including referential measurements of anisotropic phantoms. The applications of DTI for the determination of pore size distribution, tortuosity and conductivity are also shown. The study ends with a consideration of the potential prospects and challenges for DTI‐based examination of rock core samples. Plain Language Summary: An advanced nuclear magnetic resonance technique, diffusion tensor imaging (DTI), is proposed here for the characterization of rock core samples. As an example, a carbonate core sample was subjected to DTI examination, from which the diffusion tensor (DT) was obtained and DT parameters (mean diffusivity, MD; fractional anisotropy, FA; three eigenvalues; DT components and proton density, PD) were visualized in 2D and 3D. Potential examples of the practical applications of the data obtained from the DTI experiment are demonstrated. Importantly, we can now provide spatial and quantitative data which is closely related to the studied microstructure using DTI. The application of DTI for the determination of pore size distribution, tortuosity and conductivity are also shown. The study ends with a consideration of the potential prospects and challenges for the DTI‐based examination of rock core samples. Key Points: Diffusion tensor imaging enables, rotationally invariant, 3D spatial quantification of diffusion in rocks, reflecting porosity featuresPrincipal diffusion tracts may reflect permeability anisotropy and correspond to the conductivity tensorDTI ellipsoid delivers a set of parameters describing the microgeometry of average or spatially resolved pores [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

17. Sputum vitamin D binding protein (VDBP) GC1S/1S genotype predicts airway obstruction:a prospective study in smokers with COPD

Author

Gao, J. (Jing), Törölä, T. (Tanja), Li, C.-X. (Chuan-Xing), Ohlmeier, S. (Steffen), Toljamo, T. (Tuula), Nieminen, P. (Pentti), Hattori, N. (Noboru), Pulkkinen, V. (Ville), Iwamoto, H. (Hiroshi), Mazur, W. (Witold), Gao, J. (Jing), Törölä, T. (Tanja), Li, C.-X. (Chuan-Xing), Ohlmeier, S. (Steffen), Toljamo, T. (Tuula), Nieminen, P. (Pentti), Hattori, N. (Noboru), Pulkkinen, V. (Ville), Iwamoto, H. (Hiroshi), and Mazur, W. (Witold)

Abstract

Introduction: The vitamin D binding protein (VDBP, also known as GC-globulin) and vitamin D deficiency have been associated with chronic obstructive pulmonary disease (COPD). rs7041 and rs4588 are two single nucleotide polymorphisms of the VDBP gene, including three common allelic variants (GC1S, GC1F and GC2). Previous studies primarily assessed the serum levels of vitamin D and VDBP in COPD. However, less is known regarding the impact of the local release of VDBP on COPD lung function. Thus, we examined the association of sputum and plasma VDBP with lung function at baseline and at four years, and examined potential genetic polymorphism interactions. Methods: The baseline levels of sputum VDBP, plasma VDBP and plasma 25-OH vitamin D, as well as the GC rs4588 and rs7041 genotypes, were assessed in a 4-year Finnish follow-up cohort (n = 233) of non-smokers, and smokers with and without COPD. The associations between the VDBP levels and the longitudinal decline of lung function were further analysed. Results: High frequencies of the haplotypes in rs7041/rs4588 were homozygous GC1S/1S (42.5%). Higher sputum VDBP levels in stage I and stage II COPD were observed only in carriers with GC1S/1S genotype when compared with non-smokers (p = 0.034 and p = 0.002, respectively). Genotype multivariate regression analysis indicated that the baseline sputum VDBP and FEV1/FVC ratio at baseline independently predicted FEV1% at follow-up. Discussion and Conclusion: The baseline sputum VDBP expression was elevated in smokers with COPD among individuals with the GC1S/1S genotype, and predicted follow-up airway obstruction. Our results suggest that the GC polymorphism should be considered when exploring the potential of VDBP as a biomarker for COPD.

Published
2020

21. Real life results of direct acting antiviral therapy for HCV infection in HIV–HCV-coinfected patients: Epi-Ter2 study

Author

Piekarska, A., primary, Jabłonowska, E., additional, Garlicki, A., additional, Sitko, M., additional, Mazur, W., additional, Jaroszewicz, J., additional, Czauz-Andrzejuk, A., additional, Buczyńska, I., additional, Simon, K., additional, Lorenc, B., additional, Dybowska, D., additional, Halota, W., additional, Pawłowska, M., additional, Dobracka, B., additional, Berak, H., additional, Horban, A., additional, Tudrujek-Zdunek, M., additional, Tomasiewicz, K., additional, Janczewska, E., additional, Socha, Ł., additional, Laurans, Ł., additional, Parczewski, M., additional, Zarębska-Michaluk, D., additional, Pabjan, P., additional, Belica-Wdowik, T., additional, Baka-Ćwierz, B., additional, Deroń, Z., additional, Krygier, R., additional, Klapaczyński, J., additional, Citko, J., additional, Berkan-Kawińska, A., additional, and Flisiak, R., additional

Published
2019
Full Text
View/download PDF

25. Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort

Author

GUARD C, Study Group, Hassanein, T, Bakalos, G, Ahlers, S, Shiffman, Ml, Tallarico, L, Reddy, Kr, Orlandini, A, Ferenci, P, Derbala, M, Coppola, C, Foster, Gr, Basho, J, Shabanaj, G, Harxhi, A, Debzi, N, Afredj, N, Guessab, N, Mahindad, N, Mahiou, H, Aissaoui, M, Al Qameesh, J, Al Ghandoor, Z, Assene, C, Bastens, B, Brixko, C, Cool, M, De Galocsy, C, Delwaide, J, George, C, Laukens, P, Lefebvre, V, Mulkay, Jp, Nevens, F, Servais, B, Van Vlierberghe, H, Horsmans, Y, Henrion, J, Sprengers, D, Michielsen, P, Bourgeois, S, Lasser, L, Langlet, P, Robaeys, G, Martinet, Jp, Warzee, P, Hoste, P, Reynaert, H, Juriens, I, Decaestecker, J, Van Der Meersch, F, Janssens, F, Ahmetagic, S, Verhaz, A, Bevanda, M, Calkic, L, Ibrahimpasic, N, Mesihovic, R, Mello, Ce, Ruiz, Fj, Martins Junior, E, Ferraz, Ml, Silva, G, Mendes, C, Lyra, A, Silva, Mh, Gomide, G, Fernandes, Jc, Pereira, P, Correa, Mc, Teixeira, R, Yousry, A, Hanno, A, Gabr, M, Omar, A, Esmat, G, Karatapanis, S, Nikolopoulou, V, Giannoulis, G, Manolakopoulos, S, Elefsiniotis, I, Drakoulis, C, Dimitroulopoulos, D, Kanatakis, S, Ketikoglou, I, Mimidis, K, Evgenidis, N, Akriviades, E, Vafiadi Zoubouli, I, Tsianos, E, Mela, M, Orfanou, E, Mousoulis, G, Karagiannis, I, Manesis, E, Varga, M, Nemesánszky, E, Fried, K, Schuller, J, Szalay, F, Lengyel, G, Tornai, I, Banyai, T, Lesch, M, Nagy, I, Gervain, J, Tusnadi, A, Schneider, F, Szentgyörgyi, L, Hunyady, B, Vincze, A, Tolvaj, G, Varkonyi, I, Makkai, E, Enyedi, J, Racz, I, Hausinger, P, Váczi, Z, Patai, Á, Ozsvár, Z, Lakner, L, Ribiczey, P, Bhalla, A, Somani, S, Luaia, R, Rao, P, Philip, M, Lawate, P, Nagral, A, Sood, A, Parikh, S, Merat, S, Nassiri Toosi, M, Alavian, Sm, Zali, Mr, Daryani, Ne, Drenaggi, D, Attili, Af, Bandiera, F, Bassi, P, Bellati, G, Bellantani, S, Brunetto, MAURIZIA ROSSANA, Bruno, S, Castelli, F, Castellacci, R, Cattelan, Am, Colombo, M, Craxi, A, D'Angelo, S, Colombo, S, Demelia, L, Di Perri, G, Di Giacomo, A, Ferrari, C, Francisci, D, Casinelli, K, Ganga, R, Costa, C, Mangia, A, Russo, Fp, Matarazzo, F, Mazzella, G, Mazzeo, M, Memoli, M, Montalbano, M, Montalto, G, Pieri, A, Passariello, N, Picciotto, A, Pietrangelo, A, Pirisi, M, Quirino, T, Raimondo, G, Rapaccini, Gl, Rizzardini, G, Rizzetto, M, Russello, M, Sabusco, G, Santantonio, T, Soardo, G, Amedea, A, Verucchi, G, Vinelli, F, Zignego, Al, Zuin, M, Ascione, A, Vinci, M, Pigozzi, Mg, Tundo, P, Saracco, Gm, Amoroso, P, Andreoni, M, Colletta, C, Erne, E, Megna, As, Biglino, A, Chiriaco, P, Foti, G, Spinzi, G, D'Amico, E, Paik, Sw, Ahn, Sh, Lee, Yn, Kim, Y, Yang, J, Han, Sy, Varghese, R, Al Gharabally, A, Askar, H, Sharara, A, Yaghi, C, Rached, Aa, Houmani, Z, Zaarour, F, Dohaibi, A, Ivanovski, L, Joksimovic, N, Abbas, Z, Memon, S, Mohsin, A, Masood, S, Hashmi, Z, Halota, W, Deron, Z, Mazur, W, Flisiak, R, Lipczynski, A, Musialik, J, Piekarska, A, Augustyniak, K, Baka Cwierz, B, Simon, K, Gietka, A, Berak, H, Sieklucki, J, Radowska, D, Szlauer, B, Piekos, T, Olszok, I, Jablkowski, M, Orszulak, G, Warakomska, I, Aleixo, Mj, Valente, C, Macedo, G, Sarmento Castro, R, Roxo, F, Faria, T, Mansinho, K, Velez, J, Ramos, Jp, Guerreiro, H, Alberto, S, Monteverde, C, Serejo, F, Peixe, P, Malhado, J, Curescu, M, Streinu Cercel, A, Caruntu, F, Livia, H, Preotescu, L, Arama, V, Ancuta, I, Gheorghe, L, Stanciu, C, Trifan, A, Acalovschi, M, Andreica, V, Pascu, O, Lencu, M, Sporea, I, Olteanu, D, Ionita Radu, F, Fierbinteanu Braticevici, C, Motoc, A, Silaghi, R, Musat, M, Coman, F, Stan, M, Cijevschi, C, Miftode, E, Delic, D, Jesic, R, Nozic, D, Svorcan, P, Fabri, M, Konstantinovic, L, Pelemis, M, Jankovic, G, Todorovic, Z, Nagorni, A, Kupcova, V, Skladany, L, Szantova, M, Krkoska, D, Jarcuska, P, Schreter, I, Oltman, M, Bocakova, J, Bunganic, I, Holoman, J, Giguere, A, Abdou, A. M., Basic (bio-) Medical Sciences, Gastroenterology, Laboratory of Molecullar and Cellular Therapy, Liver Cell Biology, Michielsen, Peter, GUARD-C Study Group, Graham R. Foster, Carmine Coppola, Moutaz Derbala, Peter Ferenci, Alessandra Orlandini, K. Rajender Reddy, Ludovico Tallarico, Mitchell L. Shiffman, Silke Ahler, Georgios Bakalo, Tarek Hassanein, GUARD-C Study Group: [.., Davide Drenaggi, Adolfo Francesco Attili, Franco Bandiera, Paolo Bassi, Giorgio Bellati, Stefano Bellantani, Maurizia Brunetto, Savino Bruno, Francesco Castelli, Roberto Castellacci, Anna Maria Cattelan, Massimo Colombo, Antonio Craxi, Salvatore D'angelo, Silvia Colombo, Luigi Demelia, Giovanni Di Perri, Antonio Di Giacomo, Carlo Ferrari, Daniela Francisci, Katia Casinelli, Roberto Ganga, Chiara Costa, Alessandra Mangia, Francesco Paolo Russo, Filippo Matarazzo, Giuseppe Mazzella, Maurizio Mazzeo, Massimo Memoli, Marzia Montalbano, Giuseppe Montalto, Alessandro Pieri, Nicola Passariello, Antonio Picciotto, Antonello Pietrangelo, Mario Pirisi, Tiziana Quirino, Giovanni Raimondo, Gian Ludovico Rapaccini, Giuliano Rizzardini, Mario Rizzetto, Maurizio Russello, Giuseppe Sabusco, Teresa Santantonio, Giorgio Soardo, Alessandri Amedea, Gabriella Verucchi, Francesco Vinelli, Anna Linda Zignego, Massimo Zuin, Antonio Ascione, Maria Vinci, Maria Graziella Pigozzi, Paolo Tundo, Giorgio Maria Saracco, Pietro Amoroso, Massimo Andreoni, Cosimo Colletta, Elke Erne, Angelo Salomone Megna, Alberto Biglino, Piergiorgio Chiriaco, Giuseppe Foti, Giancarlo Spinzi, Emilio D'amico, …], Foster G.R., Coppola C., Derbala M., Ferenci P., Orlandini A., Reddy K.R., Tallarico L., Shiffman M.L., Ahlers S., Bakalos G., Hassanein T., Basho J., Shabanaj G., Harxhi A., Debzi N., Afredj N., Guessab N., Mahindad N., Mahiou H., Aissaoui M., Al Qameesh J., Al Ghandoor Z., Assene C., Bastens B., Brixko C., Cool M., De Galocsy C., Delwaide J., George C., Laukens P., Lefebvre V., Mulkay J.-P., Nevens F., Servais B., Van Vlierberghe H., Horsmans Y., Henrion J., Sprengers D., Michielsen P., Bourgeois S., Lasser L., Langlet P., Robaeys G., Martinet J.-P., Warzee P., Hoste P., Reynaert H., Juriens I., Decaestecker J., Van Der Meersch F., Janssens F., Ahmetagic S., Verhaz A., Bevanda M., Calkic L., Ibrahimpasic N., Mesihovic R., Mello C.E., Ruiz F.J., Junior E.M., Ferraz M.L., Silva G., Mendes C., Lyra A., Silva M.H., Gomide G., Fernandes J.C., Pereira P., Correa M.C., Teixeira R., Yousry A., Hanno A., Gabr M., Omar A., Esmat G., Karatapanis S., Nikolopoulou V., Giannoulis G., Manolakopoulos S., Elefsiniotis I., Drakoulis C., Dimitroulopoulos D., Kanatakis S., Ketikoglou I., Mimidis K., Evgenidis N., Akriviades E., Vafiadi-Zoubouli I., Tsianos E., Mela M., Orfanou E., Mousoulis G., Karagiannis I., Manesis E., Varga M., Nemesanszky E., Fried K., Schuller J., Szalay F., Lengyel G., Tornai I., Banyai T., Lesch M., Nagy I., Gervain J., Tusnadi A., Schneider F., Szentgyorgyi L., Hunyady B., Vincze A., Tolvaj G., Varkonyi I., Makkai E., Enyedi J., Racz I., Hausinger P., Vaczi Z., Patai A., Ozsvar Z., Lakner L., Ribiczey P., Bhalla A., Somani S., Luaia R., Rao P., Philip M., Lawate P., Nagral A., Sood A., Parikh S., Merat S., Nassiri-Toosi M., Alavian S.-M., Zali M.R., Daryani N.E., Drenaggi D., Attili A.F., Bandiera F., Bassi P., Bellati G., Bellantani S., Brunetto M., Bruno S., Castelli F., Castellacci R., Cattelan A.M., Colombo M., Craxi A., D'angelo S., Colombo S., Demelia L., Di Perri G., Di Giacomo A., Ferrari C., Francisci D., Casinelli K., Ganga R., Costa C., Mangia A., Russo F.P., Matarazzo F., Mazzella G., Mazzeo M., Memoli M., Montalbano M., Montalto G., Pieri A., Passariello N., Picciotto A., Pietrangelo A., Pirisi M., Quirino T., Raimondo G., Rapaccini G.L., Rizzardini G., Rizzetto M., Russello M., Sabusco G., Santantonio T., Soardo G., Amedea A., Verucchi G., Vinelli F., Zignego A.L., Zuin M., Ascione A., Vinci M., Pigozzi M.G., Tundo P., Saracco G.M., Amoroso P., Andreoni M., Colletta C., Erne E., Megna A.S., Biglino A., Chiriaco P., Foti G., Spinzi G., D'amico E., Paik S.W., Ahn S.-H., Lee Y.N., Kim Y., Yang J., Han S.Y., Varghese R., Al Gharabally A., Askar H., Sharara A., Yaghi C., Abou Rached A., Houmani Z., Zaarour F., Dohaibi A., Ivanovski L., Joksimovic N., Abbas Z., Memon S., Mohsin A., Masood S., Hashmi Z., Halota W., Deron Z., Mazur W., Flisiak R., Lipczynski A., Musialik J., Piekarska A., Augustyniak K., Baka-Cwierz B., Simon K., Gietka A., Berak H., Sieklucki J., Radowska D., Szlauer B., Piekos T., Olszok I., Jablkowski M., Orszulak G., Warakomska I., Aleixo M.J., Valente C., Macedo G., Sarmento-Castro R., Roxo F., Faria T., Mansinho K., Velez J., Ramos J.P., Guerreiro H., Alberto S., Monteverde C., Serejo F., Peixe P., Malhado J., Curescu M., Streinu-Cercel A., Caruntu F., Livia H., Preotescu L., Arama V., Ancuta I., Gheorghe L., Stanciu C., Trifan A., Acalovschi M., Andreica V., Pascu O., Lencu M., Sporea I., Olteanu D., Ionita-Radu F., Fierbinteanu-Braticevici C., Motoc A., Silaghi R., Musat M., Coman F., Stan M., Cijevschi C., Miftode E., Delic D., Jesic R., Nozic D., Svorcan P., Fabri M., Konstantinovic L., Pelemis M., Jankovic G., Todorovic Z., Nagorni A., Kupcova V., Skladany L., Szantova M., Krkoska D., Jarcuska P., Schreter I., Oltman M., Bocakova J., Bunganic I., Holoman J., Giguere A., Abdou A.M.S., UCL - SSS/IREC-Institut de recherche expérimentale et clinique, UCL - SSS/IREC/GAEN-Pôle d'Hépato-gastro-entérologie, and UCL - (SLuc) Service de gastro-entérologie

Subjects
Genetics and Molecular Biology (all), Male, Chronic Hepatitis, Hepacivirus, Ribavirin/adverse effects, Asthenia/chemically induced, Polyethylene Glycol, Biochemistry, Polyethylene Glycols, Body Mass Index, Chronic Liver Disease, 0302 clinical medicine, Neutropenia/chemically induced, Interferon-alpha/adverse effects, Medicine, Chronic, lcsh:Science, Liver Diseases, virus diseases, Antiviral Agents/adverse effects, Cohort, Science & Technology - Other Topics, 030211 gastroenterology & hepatology, Drug Therapy, Combination, Cohort study, Human, medicine.medical_specialty, Alpha interferon, Gastroenterology and Hepatology, Antiviral Agents, Microbiology, Dose-Response Relationship, 03 medical and health sciences, Pharmacotherapy, Hepatitis C, Chronic/drug therapy, Dose Prediction Methods, Drug Therapy, Anemia/chemically induced, Humans, Hemoglobin, Aged, Medicine and health sciences, Biochemistry, Genetics and Molecular Biology (all), Hepaciviru, Science & Technology, Dose-Response Relationship, Drug, Flaviviruses, lcsh:R, Organisms, Biology and Life Sciences, Proteins, medicine.disease, digestive system diseases, chemistry, Agricultural and Biological Sciences (all), Withholding Treatment, Asthenia, Immunology, Proportional Hazards Model, lcsh:Q, Human medicine, RNA viruses, Physiology, lcsh:Medicine, Peginterferon-alfa, Polyethylene Glycols/adverse effects, Adult, Anemia, Cohort Studies, Female, Hepatitis C, Chronic, Host-Pathogen Interactions, Interferon-alpha, Middle Aged, Neutropenia, Outcome Assessment (Health Care), Proportional Hazards Models, RNA, Viral, Recombinant Proteins, Ribavirin, Medicine (all), chemistry.chemical_compound, Outcome Assessment, Health Care, Medicine and Health Sciences, 030212 general & internal medicine, Viral, Pathology and laboratory medicine, Multidisciplinary, biology, Hepatitis C virus, Pharmaceutics, Hepatitis C, Hematology, Recombinant Protein, Outcome Assessment (Health Care)/methods, Medical microbiology, Host-Pathogen Interaction, Multidisciplinary Sciences, Physiological Parameters, Research Design, Combination, Viruses, Drug, Pathogens, Host-Pathogen Interactions/drug effects, Research Article, Clinical Research Design, Research and Analysis Methods, Internal medicine, Recombinant Proteins/adverse effects, RNA, Viral/blood, Antiviral Agent, business.industry, Body Weight, Hepacivirus/drug effects, Viral pathogens, biology.organism_classification, Hepatitis viruses, Microbial pathogens, RNA, Adverse Events, Cohort Studie, business
Abstract

Background: Despite the introduction of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, peginterferon alfa/ribavirin remains relevant in many resource-constrained settings. The non-randomized GUARD-C cohort investigated baseline predictors of safety-related dose reductions or discontinuations (sr-RD) and their impact on sustained virologic response (SVR) in patients receiving peginterferon alfa/ribavirin in routine practice. Methods: A total of 3181 HCV-mono-infected treatment-naive patients were assigned to 24 or 48 weeks of peginterferon alfa/ribavirin by their physician. Patients were categorized by time-to-first sr-RD (Week 4/12). Detailed analyses of the impact of sr-RD on SVR24 (HCV RNA

Published
2015

26. Real life results of direct acting antiviral therapy for HCV infection in HIV–HCV-coinfected patients: Epi-Ter2 study.

Author

Piekarska, A., Jabłonowska, E., Garlicki, A., Sitko, M., Mazur, W., Jaroszewicz, J., Czauz-Andrzejuk, A., Buczyńska, I., Simon, K., Lorenc, B., Dybowska, D., Halota, W., Pawłowska, M., Dobracka, B., Berak, H., Horban, A., Tudrujek-Zdunek, M., Tomasiewicz, K., Janczewska, E., and Socha, Ł.

Subjects
ANTIVIRAL agents, HEPATITIS C, HIV infections, CIRRHOSIS of the liver, SEX distribution, BODY mass index, TREATMENT effectiveness, DISEASE prevalence, GENOTYPES, MIXED infections
Abstract

The aim of this study was to evaluate the baseline demographics and real-life efficacy of direct acting antivirals (DAAs) in HIV–HCV-positive patients as compared to patients with HCV monoinfection. The analysis included 5690 subjects who were treated with DAAs: 5533 were HCV-positive and 157 were HIV–HCV-positive. Patients with HCV-monoinfection were older (p <.0001) and in HIV–HCV group there were more men (p <.0001). Prevalence of genotype 1a (p =.002), as well as of genotypes 3 and 4 (p <.0001) was higher in HIV–HCV-coinfected patients. Genotype 1b was more frequent (p <.0001) in the HCV-mono-infection group. Patients with HCV-monoinfection had a higher proportion of fibrosis F4 (p =.0004) and lower proportion of fibrosis F2 (p <.0001). HIV–HCV-coinfected individuals were more often treatment-naïve (p <.0001). Rates of sustained viral response after 12 weeks did not differ significantly between both groups (95.9% versus 97.3% in coinfection and monoinfection group, respectively; p >.05). They were, however, influenced by HCV genotype (p <.0001), stage of hepatic fibrosis (p <.0001), male sex (p <.0001), BMI (p =.0001) and treatment regimen modifications (p <.0001). Although factors associated with worse response to therapy (male sex, genotype 3) occurred more often in the HIV coinfection group, real-life results of DAAs did not differ significantly between both populations. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

27. Incidence and clinical implications of intraoperative bilateral internal thoracic artery graft conversion: Insights from the Arterial Revascularization Trial

Author

Benedetto, Umberto, primary, Altman, Douglas G., additional, Flather, Marcus, additional, Gerry, Stephen, additional, Gray, Alastair, additional, Lees, Belinda, additional, Taggart, David P., additional, Ratnatunga, C., additional, Westaby, S., additional, Cook, J., additional, Wallis, C., additional, Wos, S., additional, Jasinski, M., additional, Widenka, K., additional, Blach, A., additional, Gocol, R., additional, Hudziak, D., additional, Zurek, P., additional, Deja, M., additional, Bachowski, R., additional, Mrozek, R., additional, Kargul, T., additional, Domarardzki, W., additional, Frackiewicz, J., additional, Zamvar, V., additional, Ezakadan, D., additional, Buxton, B., additional, Seevanayagam, S., additional, Matalanis, G., additional, Rosalion, A., additional, Negri, J., additional, Moten, S., additional, Atkinson, V., additional, Newcomb, A., additional, Polidano, P., additional, Pana, R., additional, Gerbo, S., additional, O'Keefe, P., additional, von Oppell, U., additional, Mehta, D., additional, Azzu, A., additional, Szafranek, A., additional, Kulatilake, E., additional, Evans, J., additional, Martin, N., additional, Banner, D., additional, Trivedi, U., additional, Forsyth, A., additional, Hyde, J., additional, Cohen, A., additional, Lewis, M., additional, Gardner, E., additional, MacKenzie, A., additional, Cooter, N., additional, Joyce, E., additional, Parker, J., additional, Champney, F., additional, Clark, S., additional, Dark, J., additional, Tocewicz, K., additional, Pillay, T., additional, Rowling, S., additional, Adams-Hall, J., additional, Bochenek, A., additional, Cisowski, M., additional, Bolkowski, M., additional, Morawski, W., additional, Guc, M., additional, Krejca, M., additional, Wilczynski, M., additional, Duralek, A., additional, Gerber, W., additional, Skarysz, J., additional, Shrestha, R., additional, Swiech, W., additional, Szmagala, P., additional, Krzych, L., additional, Pawlak, A., additional, Kepa, K., additional, Hasan, R., additional, Keenan, D., additional, Prendergast, B., additional, Odom, N., additional, McLaughlin, K., additional, Cummings-Fosong, G., additional, Mathew, C., additional, Iles-Smith, H., additional, Oomen, A., additional, Desai, J., additional, El-Gamel, A., additional, John, L., additional, Wendler, O., additional, Andrews, M., additional, Rance, K., additional, Williams, R., additional, Hogervorst, V., additional, Gregory, J., additional, Jessup, J., additional, Knighton, A., additional, Hoare, A., additional, Ritchie, A., additional, Choong, C., additional, Nair, S., additional, Jenkins, D., additional, Large, S., additional, Sudarshan, C., additional, Barman, M., additional, Dhital, K., additional, Routledge, T., additional, Rosengard, B., additional, Munday, H., additional, Rintoul, K., additional, Jarrett, E., additional, Lao-Sirieix, S., additional, Wilkinson, A., additional, Garner, L., additional, Osmond, J., additional, Holcombe, H., additional, Cale, A., additional, Griffin, S., additional, Dickson, J., additional, Spyt, T., additional, Hickey, M., additional, Sosnowski, A., additional, Peek, G., additional, Szostek, J., additional, Hadjinikalaou, L., additional, Logtens, E., additional, Oakley, M., additional, Leji, S., additional, Gaer, J., additional, Amrani, M., additional, Dreyfus, G., additional, Bahrami, T., additional, de Robertis, F., additional, Baig, K., additional, Asimakopoulos, G., additional, Vohra, H., additional, Pai, V., additional, Tadjkarimi, S., additional, Soleimani, B., additional, Stavri, G., additional, Bull, G., additional, Collappen, H., additional, Sadowksi, J., additional, Gaweda, B., additional, Rudzinski, P., additional, Stolinski, J., additional, Konstanty-Kalandyk, J., additional, Moraes, F., additional, Moraes, C., additional, Wanderley, J., additional, Pepper, J., additional, De Souza, A., additional, Petrou, M., additional, Trimlett, R., additional, Morgan, T., additional, Gavino, J., additional, Wang, S.F., additional, Chandrasekaran, V., additional, Kanagasaby, R., additional, Sarsam, M., additional, Ryan, H., additional, Billings, L., additional, Ruddick, L., additional, Achampong, A., additional, Forster, E., additional, Pawlaczyk, R., additional, Siondalski, P., additional, Rogowski, J., additional, Roszak, K., additional, Jarmoszewicz, K., additional, Jagielak, D., additional, Gafka, S., additional, Mannam, G., additional, Naguboyin, G., additional, Rao Sajja, L., additional, Dandu, B., additional, Briffa, N., additional, Braidley, P., additional, Cooper, G., additional, Allen, K., additional, Sangha, G., additional, Bridge, C., additional, McMellon, H., additional, Casabona, R., additional, Actis Dato, G., additional, Bardi, G., additional, Del Ponte, S., additional, Forsennati, P., additional, Parisi, F., additional, Punta, G., additional, Flocco, R., additional, Sansone, F., additional, Zingarelli, E., additional, Dihmis, W., additional, Kuduvali, M., additional, Prince, C., additional, Rogers, H., additional, McQuade, L., additional, Anisimowicz, L., additional, Bokszanski, M., additional, Pawliszak, W., additional, Kolakowski, J., additional, Lau, G., additional, Ogorzeja, W., additional, Gumanska, I., additional, Kulinski, P., additional, Podesser, B., additional, Trescher, K., additional, Bernecker, O., additional, Holzinger, C., additional, Binder, K., additional, Schor, I., additional, Bergmann, P., additional, Kassal, H., additional, Motovova, B., additional, Trehan, N., additional, Meharwal, Z., additional, Malhotra, R., additional, Goel, M., additional, Kumer, B., additional, Bazaz, S., additional, Bake, N., additional, Singh, A., additional, Mishka, Y., additional, Gupta, R., additional, Basumatary, S., additional, Zembala, M., additional, Szafron, B., additional, Pacholewicz, J., additional, Krason, M., additional, Farmas, A., additional, Wojarski, J., additional, Zych, B., additional, Szymanik, I., additional, Kolwca, M., additional, Mazur, W., additional, Kurowicki, A., additional, Zurek, S., additional, Stacel, T., additional, Jaworska, I., additional, Sleight, P., additional, Channon, K., additional, Farrell, B., additional, Stables, R., additional, Vermes, G., additional, Pearson, J., additional, Pitman, M., additional, Yusuf, S., additional, Pocock, S., additional, Julian, D., additional, Treasure, T., additional, Von Oppel, U., additional, Kanagasabay, R., additional, Collinson, J., additional, Bakhai, A., additional, O'Hanlon, R., additional, Kotecha, D., additional, Qureshi, K., additional, Geisler, T., additional, and Manzano-Espinosa, L., additional

Published
2018
Full Text
View/download PDF

28. The efficacy of paritaprevir/ritonavir/ombitasvir + dasabuvir and ledipasvir/sofosbuvir is similar in patients who failed interferon-based treatment with first generation protease inhibitors

Author

Janczewska, E., primary, Flisiak, R., additional, Zarebska-Michaluk, D., additional, Arkadiusz, P., additional, Staniaszek, A., additional, Gietka, A., additional, Mazur, W., additional, Tudrujek, M., additional, Tomasiewicz, K., additional, Belica-Wdowik, T., additional, Baka-Cwierz, B., additional, Dybowska, D., additional, Halota, W., additional, Lorenc, B., additional, Sitko, M., additional, Garlicki, A., additional, Berak, H., additional, Andrzej, H., additional, Orłowska, I., additional, Krzysztof, S., additional, Socha, Ł., additional, Wawrzynowicz-Syczewska, M., additional, Jaroszewicz, J., additional, Zbigniew, D., additional, Czauż-Andrzejuk, A., additional, Citko, J., additional, Krygier, R., additional, Piekarska, A., additional, Laurans, Ł., additional, Dobracka, B., additional, Bialkowska-Warzecha, J., additional, Olga, T., additional, and Pawłowska, M., additional

Published
2018
Full Text
View/download PDF

29. Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial)

Author

Benedetto, Umberto, primary, Altman, Douglas G., additional, Gerry, Stephen, additional, Gray, Alastair, additional, Lees, Belinda, additional, Angelini, Gianni D., additional, Flather, Marcus, additional, Taggart, David P., additional, Ratnatunga, C., additional, Westaby, S., additional, Cook, J., additional, Wallis, C., additional, Wos, S., additional, Jasinski, M., additional, Widenka, K., additional, Blach, A., additional, Gocol, R., additional, Hudziak, D., additional, Zurek, P., additional, Deja, M., additional, Bachowski, R., additional, Mrozek, R., additional, Kargul, T., additional, Domarardzki, W., additional, Frackiewicz, J., additional, Zamvar, V., additional, Ezakadan, D., additional, Buxton, B., additional, Seevanayagam, S., additional, Matalanis, G., additional, Rosalion, A., additional, Negri, J., additional, Moten, S., additional, Atkinson, V., additional, Newcomb, A., additional, Polidano, P., additional, Pana, R., additional, Gerbo, S., additional, O'Keefe, P., additional, von Oppell, U., additional, Mehta, D., additional, Azzu, A., additional, Szafranek, A., additional, Kulatilake, E., additional, Evans, J., additional, Martin, N., additional, Banner, D., additional, Trivedi, U., additional, Forsyth, A., additional, Hyde, J., additional, Cohen, A., additional, Lewis, M., additional, Gardner, E., additional, MacKenzie, A., additional, Cooter, N., additional, Joyce, E., additional, Parker, J., additional, Champney, F., additional, Clark, S., additional, Dark, J., additional, Tocewicz, K., additional, Pillay, T., additional, Rowling, S., additional, Adams‐Hall, J., additional, Bochenek, A., additional, Cisowski, M., additional, Bolkowski, M., additional, Morawski, W., additional, Guc, M., additional, Krejca, M., additional, Wilczynski, M., additional, Duralek, A., additional, Gerber, W., additional, Skarysz, J., additional, Shrestha, R., additional, Swiech, W., additional, Szmagala, P., additional, Krzych, L., additional, Pawlak, A., additional, Kepa, K., additional, Hasan, R., additional, Keenan, D., additional, Prendergast, B., additional, Odom, N., additional, McLaughlin, K., additional, Cummings‐Fosong, G., additional, Mathew, C., additional, Iles‐Smith, H., additional, Oomen, A., additional, Desai, J., additional, El‐Gamel, A., additional, John, L., additional, Wendler, O., additional, Andrews, M., additional, Rance, K., additional, Williams, R., additional, Hogervorst, V., additional, Gregory, J., additional, Jessup, J., additional, Knighton, A., additional, Hoare, A., additional, Ritchie, A., additional, Choong, C., additional, Nair, S., additional, Jenkins, D., additional, Large, S., additional, Sudarshan, C., additional, Barman, M., additional, Dhital, K., additional, Routledge, T., additional, Rosengard, B., additional, Munday, H., additional, Rintoul, K., additional, Jarrett, E., additional, Lao‐Sirieix, S., additional, Wilkinson, A., additional, Garner, L., additional, Osmond, J., additional, Holcombe, H., additional, Cale, A., additional, Griffin, S., additional, Dickson, J., additional, Spyt, T., additional, Hickey, M., additional, Sosnowski, A., additional, Peek, G., additional, Szostek, J., additional, Hadjinikalaou, L., additional, Logtens, E., additional, Oakley, M., additional, Leji, S., additional, Gaer, J., additional, Amrani, M., additional, Dreyfus, G., additional, Bahrami, T., additional, de Robertis, F., additional, Baig, K., additional, Asimakopoulos, G., additional, Vohra, H., additional, Pai, V., additional, Tadjkarimi, S., additional, Soleimani, B., additional, Stavri, G., additional, Bull, G., additional, Collappen, H., additional, Sadowksi, J., additional, Gaweda, B., additional, Rudzinski, P., additional, Stolinski, J., additional, Konstanty‐Kalandyk, J., additional, Moraes, F., additional, Moraes, C., additional, Wanderley, J., additional, Pepper, J., additional, De Souza, A., additional, Petrou, M., additional, Trimlett, R., additional, Morgan, T., additional, Gavino, J., additional, Wang, S.F., additional, Chandrasekaran, V., additional, Kanagasaby, R., additional, Sarsam, M., additional, Ryan, H., additional, Billings, L., additional, Ruddick, L., additional, Achampong, A., additional, Forster, E., additional, Pawlaczyk, R., additional, Siondalski, P., additional, Rogowski, J., additional, Roszak, K., additional, Jarmoszewicz, K., additional, Jagielak, D., additional, Gafka, S., additional, Mannam, G., additional, Naguboyin, G., additional, Rao Sajja, L., additional, Dandu, B., additional, Briffa, N., additional, Braidley, P., additional, Cooper, G., additional, Allen, K., additional, Sangha, G., additional, Bridge, C., additional, McMellon, H., additional, Casabona, R., additional, Actis Dato, G., additional, Bardi, G., additional, Del Ponte, S., additional, Forsennati, P., additional, Parisi, F., additional, Punta, G., additional, Flocco, R., additional, Sansone, F., additional, Zingarelli, E., additional, Dihmis, W., additional, Kuduvali, M., additional, Prince, C., additional, Rogers, H., additional, McQuade, L., additional, Anisimowicz, L., additional, Bokszanski, M., additional, Pawliszak, W., additional, Kolakowski, J., additional, Lau, G., additional, Ogorzeja, W., additional, Gumanska, I., additional, Kulinski, P., additional, Podesser, B., additional, Trescher, K., additional, Bernecker, O., additional, Holzinger, C., additional, Binder, K., additional, Schor, I., additional, Bergmann, P., additional, Kassal, H., additional, Motovova, B., additional, Trehan, N., additional, Meharwal, Z., additional, Malhotra, R., additional, Goel, M., additional, Kumer, B., additional, Bazaz, S., additional, Bake, N., additional, Singh, A., additional, Mishka, Y., additional, Gupta, R., additional, Basumatary, S., additional, Zembala, M., additional, Szafron, B., additional, Pacholewicz, J., additional, Krason, M., additional, Farmas, A., additional, Wojarski, J., additional, Zych, B., additional, Szymanik, I., additional, Kolwca, M., additional, Mazur, W., additional, Kurowicki, A., additional, Zurek, S., additional, Stacel, T., additional, Jaworska, I., additional, Sleight, P., additional, Channon, K., additional, Farrell, B., additional, Stables, R., additional, Vermes, G., additional, Pearson, J., additional, Pitman, M., additional, Yusuf, S., additional, Pocock, S., additional, Julian, D., additional, Treasure, T., additional, Von Oppel, U., additional, Kanagasabay, R., additional, Collinson, J., additional, Bakhai, A., additional, O'Hanlon, R., additional, Kotecha, D., additional, Qureshi, K., additional, Geisler, T., additional, and Manzano‐Espinosa, L., additional

Published
2018
Full Text
View/download PDF

30. Treatment of HCV infection in Poland at the beginning of the interferon-free era-the EpiTer-2 study

Author

Flisiak, R., primary, Zarębska-Michaluk, D., additional, Janczewska, E., additional, Staniaszek, A., additional, Gietka, A., additional, Mazur, W., additional, Tudrujek, M., additional, Tomasiewicz, K., additional, Belica-Wdowik, T., additional, Baka-Ćwierz, B., additional, Dybowska, D., additional, Halota, W., additional, Lorenc, B., additional, Sitko, M., additional, Garlicki, A., additional, Berak, H., additional, Horban, A., additional, Orłowska, I., additional, Simon, K., additional, Socha, Ł., additional, Wawrzynowicz-Syczewska, M., additional, Jaroszewicz, J., additional, Deroń, Z., additional, Czauż-Andrzejuk, A., additional, Citko, J., additional, Krygier, R., additional, Piekarska, A., additional, Laurans, Ł., additional, Dobracki, W., additional, Białkowska, J., additional, Tronina, O., additional, and Pawłowska, M., additional

Published
2018
Full Text
View/download PDF

32. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia

Author

Afdhal NH, Giannini EG, Tayyab G, Mohsin A, Lee JW, Andriulli A, Jeffers L, McHutchison J, Chen PJ, Han KH, Campbell F, Hyde D, Brainsky A, Theodore D, ELEVATE Study Group […, Akram J, Bessonova E, Bilodeau M, Bloomer J, Botta Fridlund D, Bzowej N, Calmus Y, Carbonell N, Caro Patón A, Cholewinska G, Chuang WL, Colombato L, Colombo M, Craxi A, Di Leo A, Diago M, Dumortier J, Elkasahab M, Everson G, Fallon M, Fedeli G, Finazzi R, Fontanella A, Francavilla A, Gadano A, Gambarin Gelwan M, Gordon F, Graus Morales J, Grieco A, Gugenheim J, Homenda W, Iaquinto G, Kang H, Khan Z, Kuliczkowski K, Kwo P, Lee JH, Lee W, Lee YS, Mazur W, Moreno C, Morozov V, Muñoz A, Navasa Anadón M, Nijhawan S, Pinzello G, Poordad F, Prieto Castillo M, Rafalsky V, Rapaccini G, Regenstein F, Rewak W, Riley T, Ripoll Noiseux C, Rizzetto M, Rodrigo Lopez J, Russo M, Samuel D, Sánchez Antolín G, Satyanaryana R, Savarino V, Shiffman M, Sigal S, Solá Lamoglia R, Sterling R, Tanno H, Te H, Terg R, Thuluvath P, Trepo C, Vargas H, Xiol Quingles X, Zaman A, Fontana R, Kim K, Abrams C, Gish R, Cardenas A, ANDREONE, PIETRO, MAZZELLA, GIUSEPPE, Afdhal, NH, Giannini, EG, Tayyab, G, Mohsin, A, Lee, JW, Andriulli, A, Jeffers, L, McHutchison, J, Chen, PJ, Han, KH, Campbell, F, Hyde, D, Brainsky, A, Theodore, D, Craxi, A, Afdhal NH, Giannini EG, Tayyab G, Mohsin A, Lee JW, Andriulli A, Jeffers L, McHutchison J, Chen PJ, Han KH, Campbell F, Hyde D, Brainsky A, Theodore D, ELEVATE Study Group […, Akram J, Andreone P, Bessonova E, Bilodeau M, Bloomer J, Botta-Fridlund D, Bzowej N, Calmus Y, Carbonell N, Caro Patón A, Cholewinska G, Chuang WL, Colombato L, Colombo M, Craxi A, Di Leo A, Diago M, Dumortier J, Elkasahab M, Everson G, Fallon M, Fedeli G, Finazzi R, Fontanella A, Francavilla A, Gadano A, Gambarin-Gelwan M, Gordon F, Graus Morales J, Grieco A, Gugenheim J, Homenda W, Iaquinto G, Kang H, Khan Z, Kuliczkowski K, Kwo P, Lee JH, Lee W, Lee YS, Mazur W, Mazzella G, Moreno C, Morozov V, Muñoz A, Navasa Anadón M, Nijhawan S, Pinzello G, Poordad F, Prieto Castillo M, Rafalsky V, Rapaccini G, Regenstein F, Rewak W, Riley T, Ripoll Noiseux C, Rizzetto M, Rodrigo Lopez J, Russo M, Samuel D, Sánchez Antolín G, Satyanaryana R, Savarino V, Shiffman M, Sigal S, Solá Lamoglia R, Sterling R, Tanno H, Te H, Terg R, Thuluvath P, Trepo C, Vargas H, Xiol Quingles X, Zaman A, Fontana R, Kim K, Abrams C, Gish R, Cardenas A, and …]

Subjects
Liver Cirrhosis, Male, Cirrhosis, Chronic liver disease, Benzoates, law.invention, chemistry.chemical_compound, Randomized controlled trial, law, Receptors, Clinical endpoint, 80 and over, Medicine, CIRRHOSIS, Aged, 80 and over, Benzoic Acids, General Medicine, CHRONIC LIVER DISEASE, Middle Aged, Hydrazines, Thrombopoietin, Elective Surgical Procedures, Anesthesia, Female, Elective Surgical Procedure, Receptors, Thrombopoietin, Adult, Adolescent, Eltrombopag, ELTROMBOPAG, Hemorrhage, Platelet Transfusion, Placebo, Young Adult, Double-Blind Method, Elective, Surgical Procedures, Elective, Humans, Aged, THROMBOCYTOPENIA, Surgical Procedures, business.industry, Platelet Count, cirrhosis, Settore MED/09 - MEDICINA INTERNA, medicine.disease, Thrombocytopenia, Platelet transfusion, chemistry, Chronic Disease, Pyrazoles, business
Abstract

Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet transfusions in patients with thrombocytopenia and chronic liver disease who are undergoing an elective invasive procedure.We randomly assigned 292 patients with chronic liver disease of diverse causes and platelet counts of less than 50,000 per cubic millimeter to receive eltrombopag, at a dose of 75 mg daily, or placebo for 14 days before a planned elective invasive procedure that was performed within 5 days after the last dose. The primary end point was the avoidance of a platelet transfusion before, during, and up to 7 days after the procedure. A key secondary end point was the occurrence of bleeding (World Health Organization [WHO] grade 2 or higher) during this period.A platelet transfusion was avoided in 104 of 145 patients who received eltrombopag (72%) and in 28 of 147 who received placebo (19%) (P0.001). No significant difference between the eltrombopag and placebo groups was observed in bleeding episodes of WHO grade 2 or higher, which were reported in 17% and 23% of patients, respectively. Thrombotic events of the portal venous system were observed in 6 patients who received eltrombopag, as compared with 1 who received placebo, resulting in the early termination of the study. The incidence and severity of other adverse events were similar in the eltrombopag and placebo groups.Eltrombopag reduced the need for platelet transfusions in patients with chronic liver disease who were undergoing elective invasive procedures, but it was associated with an increased incidence of portal-vein thrombosis, as compared with placebo. (Funded by GlaxoSmithKline; ELEVATE ClinicalTrials.gov number, NCT00678587.).

Published
2012

33. VII Scandinavian Copd Research Symposium, Holmenkollen, Oslo 18th–19th November 2016

Author

Lindberg, A., Holm, Are M., Hilberg, O., Harju, T., Vestbo, Jorgen, Foronjy, Robert, Harju, Terttu, Nurmos, Ninni-Ingrid, Karvonen, Henna, Lappi-Blanco, Elisa, Skold, Magnus, Lehtonen, Siri, Kaarteenaho, Riitta, Backman, Helena, Christensen, V. L., Rustoen, T., Cooper, B. A., Miaskowski, Christine, Henriksen, A. H., Bentsen, S. B., Andersson, Mikael, Waatevik, Marie, Johannessen, Ane, Real, Francisco Gomez, Aanerud, Marianne, Hardie, Jon Andrew, Bakke, Per Sigvald, Eagan, Tomas Mikal Lind, Farver-Vestergaard, Ingeborg, Ottesen, Anders Lokke, Bendstrup, Elisabeth, O'Connor, Maja, Zachariae, Robert, Törölä, T., Nieminen, P., Ohlmeier, S., Gao, J., Toljamo, T., Mazur, W., Pulkkinen, V., Andreassen, Siw L., Christensen, Vivi L., Rustoen, Tone, Klingenberg, Olav, Aarberge, Ingebord, Jarenback, Linnea, Kaasgaard, Mette, Clinicum, Department of Medicine, Keuhkosairauksien yksikkö, HUS Heart and Lung Center, and HUS Internal Medicine and Rehabilitation

Subjects
lcsh:RC705-779, Pulmonary and Respiratory Medicine, COPD, medicine.medical_specialty, STATEMENT, business.industry, Respiratory Medicine and Allergy, education, Physical activity, lcsh:Diseases of the respiratory system, medicine.disease, OBSTRUCTIVE PULMONARY-DISEASE, 03 medical and health sciences, PHYSICAL-ACTIVITY, 0302 clinical medicine, 030228 respiratory system, 3121 General medicine, internal medicine and other clinical medicine, Family medicine, medicine, 030212 general & internal medicine, Medical science, business, Abstract, Lungmedicin och allergi
Abstract

The overall aim of this thesis was to assess measurement properties of methods suitable for screening or monitoring of physical capacity and physical activity in subjects with chronic obstructive p ...

Published
2017
Full Text
View/download PDF

34. Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials

Author

Dore, GJ, Conway, B, Luo, Y, Janczewska, E, Knysz, B, Liu, Y, Streinu-Cercel, A, Caruntu, FA, Curescu, M, Skoien, R, Ghesquiere, W, Mazur, W, Soza, A, Fuster, F, Greenbloom, S, Motoc, A, Arama, V, Shaw, D, Tornai, I, Sasadeusz, J, Dalgard, O, Sullivan, D, Liu, X, Kapoor, M, Campbell, A, Podsadecki, T, Dore, GJ, Conway, B, Luo, Y, Janczewska, E, Knysz, B, Liu, Y, Streinu-Cercel, A, Caruntu, FA, Curescu, M, Skoien, R, Ghesquiere, W, Mazur, W, Soza, A, Fuster, F, Greenbloom, S, Motoc, A, Arama, V, Shaw, D, Tornai, I, Sasadeusz, J, Dalgard, O, Sullivan, D, Liu, X, Kapoor, M, Campbell, A, and Podsadecki, T

Abstract

Background & Aims Telaprevir plus pegylated interferon/ribavirin (TPV + PegIFN/RBV) remains a therapeutic option for chronic hepatitis C virus (HCV) genotype (GT) 1 infection in many regions. We conducted two open-label, phase IIIb trials comparing safety and efficacy of all-oral ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin (OBV/PTV/r + DSV ± RBV) and TPV + PegIFN/RBV. Methods Treatment-naïve (MALACHITE-I) or PegIFN/RBV-experienced (MALACHITE-II) non-cirrhotic, chronic HCV GT1-infected patients were randomized to OBV/PTV/r + DSV + weight-based RBV, OBV/PTV/r + DSV (treatment-naïve, GT1b-infected patients only), or 12 weeks of TPV + PegIFN + weight-based RBV and 12-36 additional weeks of PegIFN/RBV. The primary endpoint was sustained virologic response 12 weeks post-treatment (SVR12). Patient-reported outcome questionnaires evaluated mental and physical health during the studies. Results Three hundred eleven treatment-naïve and 148 treatment-experienced patients were randomized and dosed. Among treatment-naïve patients, SVR12 rates were 97% (67/69) and 82% (28/34), respectively, in OBV/PTV/r + DSV + RBV and TPV + PegIFN/RBV-treated GT1a-infected patients; SVR12 rates were 99% (83/84), 98% (81/83), and 78% (32/41) in OBV/PTV/r + DSV + RBV, OBV/PTV/r + DSV, and TPV + PegIFN/RBV-treated GT1b-infected patients. Among treatment-experienced patients, SVR12 rates were 99% (100/101) and 66% (31/47) with OBV/PTV/r + DSV + RBV and TPV + PegIFN/RBV. Mental and physical health were generally better with OBV/PTV/r + DSV ± RBV than TPV + PegIFN/RBV. Rates of discontinuation due to adverse events (0-1% and 8-11%, respectively, p <0.05) and rates of hemoglobin decline to <10 g/dl (0-4% and 34-47%, respectively, p <0.05) were lower for OBV/PTV/r + DSV ± RBV than TPV + PegIFN/RBV. Conclusions Among non-cirrhotic, HCV GT1-infected patients, SVR12 rates were 97-99% with 12 week, multi-targeted OBV/PTV/r + DSV ± RBV regimens and 66-82% with 24-48 total weeks of TPV + PegIF

Published
2016

35. Diagnostic performance of treadmill exercise cardiac magnetic resonance: The prospective, multicenter exact trial

Author

Raman, SV, Dickerson, JA, Mazur, W, Wong, TC, Schelbert, EB, Scandling, D, Craft, J, Min, J, Bartone, C, Mazzaferri, EL, Thavendiranathan, P, Arnold, J, Gilkeson, R, Simonetti, OP, Raman, SV, Dickerson, JA, Mazur, W, Wong, TC, Schelbert, EB, Scandling, D, Craft, J, Min, J, Bartone, C, Mazzaferri, EL, Thavendiranathan, P, Arnold, J, Gilkeson, R, and Simonetti, OP

Published
2016

36. THU-331 - The efficacy of paritaprevir/ritonavir/ombitasvir + dasabuvir and ledipasvir/sofosbuvir is similar in patients who failed interferon-based treatment with first generation protease inhibitors

Author

Janczewska, E., Flisiak, R., Zarebska-Michaluk, D., Arkadiusz, P., Staniaszek, A., Gietka, A., Mazur, W., Tudrujek, M., Tomasiewicz, K., Belica-Wdowik, T., Baka-Cwierz, B., Dybowska, D., Halota, W., Lorenc, B., Sitko, M., Garlicki, A., Berak, H., Andrzej, H., Orłowska, I., Krzysztof, S., Socha, Ł., Wawrzynowicz-Syczewska, M., Jaroszewicz, J., Zbigniew, D., Czauż-Andrzejuk, A., Citko, J., Krygier, R., Piekarska, A., Laurans, Ł., Dobracka, B., Bialkowska-Warzecha, J., Olga, T., and Pawłowska, M.

Published
2018
Full Text
View/download PDF

38. MALACHITE-II: PHASE 3B TRIAL OF OMBITASVIR/PARITAPREVIR/R AND DASABUVIR plus RIBAVIRIN OR TELAPREVIR plus PEGINTERFERON/RIBAVIRIN IN PEGINTERFERON/RIBAVIRIN TREATMENT-EXPERIENCED ADULTS WITH HCV GENOTYPE 1

Author

Dore, G, Knysz, B, Luo, Y, Janczewska, E, Streinu-Cercel, A, Caruntu, FA, Motoc, A, Mazur, W, Shaw, D, Tornai, I, Sasadeusz, J, Skoien, R, Sullivan, D, Liu, X, Podsadecki, T, Dore, G, Knysz, B, Luo, Y, Janczewska, E, Streinu-Cercel, A, Caruntu, FA, Motoc, A, Mazur, W, Shaw, D, Tornai, I, Sasadeusz, J, Skoien, R, Sullivan, D, Liu, X, and Podsadecki, T

Published
2015

40. P0847 : Malachite-II: Phase 3b trial of ombitasvir/paritaprevir/r and dasabuvir + ribavirin or telaprevir + peginterferon/ribavirin in peginterferon/ribavirin treatment-experienced adults with HCV genotype 1

Author

Dore, G., primary, Knysz, B., additional, Luo, Y., additional, Janczewska, E., additional, Streinu-Cercel, A., additional, Caruntu, F.A., additional, Motoc, A., additional, Mazur, W., additional, Shaw, D., additional, Tornai, I., additional, Sasadeusz, J., additional, Skoien, R., additional, Sullivan, D., additional, Liu, X., additional, and Podsadecki, T., additional

Published
2015
Full Text
View/download PDF

42. P0842 : Malachite-I: Phase 3B Trial of ombitasvir/paritaprevir/r and dasabuvir +/− ribavirin or telaprevir + peginterferon/ribavirin in treatment-naïve adults with HCV genotype 1

Author

Conway, B., primary, Janczewska, E., additional, Luo, Y., additional, Curescu, M., additional, Greenbloom, S., additional, Streinu-Cercel, A., additional, Caruntu, F.A., additional, Ghesquiere, W., additional, Knysz, B., additional, Mazur, W., additional, Fuster, F., additional, Motoc, A., additional, Soza, A., additional, Arama, V., additional, Dalgard, O., additional, Sullivan, D., additional, Liu, X., additional, and Podsadecki, T., additional

Published
2015
Full Text
View/download PDF

44. These abstracts have been selected for VIEWING only as ePosters and in print. ePosters will be available on Screen A & B throughout the meeting, Print Posters at the times indicated below. Please refer to the PROGRAM for more details.

Author

Secchi, F., primary, Cannao, P., additional, Pluchinotta, F., additional, Butera, G., additional, Carminati, M., additional, Sardanelli, F., additional, Lombardi, M., additional, Monney, P., additional, Piccini, D., additional, Rutz, T., additional, Vincenti, G., additional, Coppo, S., additional, Koestner, S., additional, Stuber, M., additional, Schwitter, J., additional, Romana, P., additional, Francesco, S., additional, Gianfranco, B., additional, Mario, C., additional, Massimo, L., additional, Alizadeh Sani, Z., additional, Vojdan-Parast, M., additional, Alimohammadi, M., additional, Sarafan-Sadeghi, S., additional, Seifi, A., additional, Fallahabadi, H., additional, Karami Tanha, F., additional, Jamshidi, M., additional, Hesamy, M., additional, Bonello, B., additional, Sorensen, C., additional, Fouilloux, V., additional, Gorincour, G., additional, Mace, L., additional, Fraisse, A., additional, Jacquier, A., additional, de Meester, C., additional, Amzulescu, M., additional, Bouzin, C., additional, Boileau, L., additional, Melchior, J., additional, Boulif, J., additional, Lazam, S., additional, Pasquet, A., additional, Vancrayenest, D., additional, Vanoverschelde, J., additional, Gerber, B., additional, Loudon, M., additional, Bull, S., additional, Bissell, M., additional, Joseph, J., additional, Neubauer, S., additional, Myerson, S., additional, Dorniak, K., additional, Hellmann, M., additional, Rawicz-Zegrzda, D., additional, W sierska, M., additional, Sabisz, A., additional, Szurowska, E., additional, Heiberg, E., additional, Dudziak, M., additional, Kwok, T., additional, Chin, C., additional, Dweck, M., additional, Hadamitzky, M., additional, Nadjiri, J., additional, Hendrich, E., additional, Pankalla, C., additional, Will, A., additional, Schunkert, H., additional, Martinoff, S., additional, Sonne, C., additional, Pepe, A., additional, Meloni, A., additional, Terrazzino, F., additional, Spasiano, A., additional, Filosa, A., additional, Bitti, P., additional, Tangari, C., additional, Restaino, G., additional, Resta, M., additional, Ricchi, P., additional, Tudisca, C., additional, Grassedonio, E., additional, Positano, V., additional, Piraino, B., additional, Romano, N., additional, Keilberg, P., additional, Midiri, M., additional, Macchi, S., additional, Ambrosio, D., additional, De Marchi, D., additional, Chiodi, E., additional, Salvatori, C., additional, Artang, R., additional, Bogachkov, A., additional, Botelho, M., additional, Bou-Ayache, J., additional, Vazquez, M., additional, Carr, J., additional, Collins, J., additional, Maret, E., additional, Ahlander, B., additional, Bjorklund, P., additional, Engvall, J., additional, Cimermancic, R., additional, Inage, A., additional, Mizuno, N., additional, Santarelli, M., additional, Izzi, G., additional, Maddaloni, D., additional, Landini, L., additional, Carulli, G., additional, Oliva, E., additional, Arcioni, F., additional, Fraticelli, V., additional, Toia, P., additional, Renne, S., additional, Rizzo, M., additional, Reinstadler, S., additional, Klug, G., additional, Feistritzer, H., additional, Aschauer, A., additional, Schocke, M., additional, Franz, W., additional, Metzler, B., additional, Melonil, A., additional, Positanol, V., additional, Roccamo, G., additional, Argento, C., additional, Benni, M., additional, De Marchil, D., additional, Missere, M., additional, Prezios, P., additional, Salvatoril, C., additional, Pepel, A., additional, Rossi, G., additional, Cirotto, C., additional, Filati, G., additional, Preziosi, P., additional, Mongeon, F., additional, Fischer, K., additional, Teixeira, T., additional, Friedrich, M., additional, Marcotte, F., additional, Zenge, M., additional, Schmidt, M., additional, Nadar, M., additional, Chevre, P., additional, Rohner, C., additional, Mouratoglou, S., additional, Kallifatidis, A., additional, Giannakoulas, G., additional, Grapsa, J., additional, Kamperidis, V., additional, Pitsiou, G., additional, Stanopoulos, I., additional, Hadjimiltiades, S., additional, Karvounis, H., additional, Ahmed, N., additional, Lawton, C., additional, Ghosh Dastidar, A., additional, Frontera, A., additional, Jackson, A., additional, Cripps, T., additional, Diab, I., additional, Duncan, E., additional, Thomas, G., additional, Bucciarelli-Ducci, C., additional, Kannoly, S., additional, Gosling, O., additional, Ninan, T., additional, Fulford, J., additional, Dalrymple-Haym, M., additional, Shore, A., additional, Bellenger, N., additional, Alegret, J., additional, Beltran, R., additional, Martin, M., additional, Mendoza, M., additional, Elisabetta, C., additional, Teresa, C., additional, Zairo, F., additional, Marcello, N., additional, Clorinda, M., additional, Bruna, M., additional, Vincenzo, P., additional, Alessia, P., additional, Giorgio, B., additional, Mair, J., additional, Kremser, C., additional, Aschauer, S., additional, Tufaro, C., additional, Kammerlander, A., additional, Pfaffenberger, S., additional, Marzluf, B., additional, Bonderman, D., additional, Mascherbauer, J., additional, Kliegel, A., additional, Sailer, A., additional, Brustbauer, R., additional, Sedivy, R., additional, Mayr, H., additional, Manessi, M., additional, Castelvecchio, S., additional, Votta, E., additional, Stevanella, M., additional, Menicanti, L., additional, Secchi, F., additional, Redaelli, A., additional, Reiter, U., additional, Reiter, G., additional, Kovacs, G., additional, Greiser, A., additional, Olschewski, H., additional, Fuchsjager, M., additional, Babayev, J., additional, Mlynarski, R., additional, Mlynarska, A., additional, Sosnowski, M., additional, Pontone, G., additional, Bertella, E., additional, Petulla, M., additional, Russo, E., additional, Innocenti, E., additional, Baggiano, A., additional, Mushtaq, S., additional, Gripari, P., additional, Andreini, D., additional, Tondo, C., additional, Nyktari, E., additional, Izgi, C., additional, Haidar, S., additional, Wage, R., additional, Keegan, J., additional, Wong, T., additional, Mohiaddin, R., additional, Durante, A., additional, Rimoldi, O., additional, Laforgia, P., additional, Gianni, U., additional, Benedetti, G., additional, Cava, M., additional, Damascelli, A., additional, Laricchia, A., additional, Ancona, M., additional, Aurelio, A., additional, Pizzetti, G., additional, Esposito, A., additional, Margonato, A., additional, Colombo, A., additional, De Cobelli, F., additional, Camici, P., additional, Zvaigzne, L., additional, Sergejenko, S., additional, Kal js, O., additional, Ripley, D., additional, Swarbrick, D., additional, Hossain, E., additional, Chawner, R., additional, Moore, J., additional, Aquaro, G., additional, Barison, A., additional, Masci, P., additional, Todiere, G., additional, Strata, E., additional, Di Bella, G., additional, Monasterio, F., additional, Levelt, E., additional, Mahmod, M., additional, Ntusi, N., additional, Ariga, R., additional, Upton, R., additional, Piechnick, S., additional, Francis, J., additional, Schneider, J., additional, Stoll, V., additional, Davis, A., additional, Karamitsos, T., additional, Leeson, P., additional, Holloway, C., additional, Clarke, K., additional, Karwat, K., additional, Tomala, M., additional, Miszalski-Jamka, K., additional, Mrozi ska, S., additional, Kowalczyk, M., additional, Mazur, W., additional, Kereiakes, D., additional, Nessler, J., additional, Zmudka, K., additional, Ja wiec, P., additional, Miszalski-Jamka, T., additional, Ben Yaacoub-Kzadri, I., additional, Harguem, S., additional, Bennaceur, R., additional, Ganzoui, I., additional, Ben Miled, A., additional, Mnif, N., additional, Rodriguez Palomares, J., additional, Ortiz, J., additional, Tejedor, P., additional, Lee, D., additional, Wu, E., additional, Bonow, R., additional, Khanji, M., additional, Castiello, T., additional, Westwood, M., additional, Petersen, S., additional, Storti, S., additional, Quota, A., additional, Smacchia, M., additional, Paci, C., additional, Vallone, A., additional, Valeri, G., additional, keilberg, P., additional, Gargani, L., additional, Guiducci, S., additional, Pugliese, N., additional, Pingitore, A., additional, Cole, B., additional, Douglas, H., additional, Rodden, S., additional, Horan, P., additional, Harbinson, M., additional, Johnston, N., additional, Dixon, L., additional, Choudhary, P., additional, Hsu, C., additional, Grieve, S., additional, Semsarian, C., additional, Richmond, D., additional, Celermajer, D., additional, Puranik, R., additional, Hinojar Baydes, R., additional, Varma, N., additional, Goodman, B., additional, Khan, S., additional, Arroyo Ucar, E., additional, Dabir, D., additional, Schaeffter, T., additional, Nagel, E., additional, Puntmann, V., additional, Hinojar, R., additional, Ucar, E., additional, Ngah, N., additional, Kuo, N., additional, D'Cruz, D., additional, Gaddum, N., additional, Foote, L., additional, Schnackenburg, B., additional, Higgins, D., additional, Nucifora, G., additional, Muser, D., additional, Morocutti, G., additional, Gianfagna, P., additional, Zanuttini, D., additional, Piccoli, G., additional, Proclemer, A., additional, Prati, G., additional, Vitrella, G., additional, Allocca, G., additional, Buttignoni, S., additional, Delise, P., additional, Sinagra, G., additional, Silva, G., additional, Almeida, A., additional, David, C., additional, Francisco, A., additional, Magalhaes, A., additional, Placido, R., additional, Menezes, M., additional, Guimaraes, T., additional, Mendes, A., additional, Nunes Diogo, A., additional, Aneq, M., additional, Papavassiliu, T., additional, Sandberg, R., additional, Schimpf, R., additional, Schoenberg, S., additional, Borggrefe, M., additional, Doesch, C., additional, Tamin, S., additional, Tan, L., additional, Joshi, S., additional, Memon, S., additional, Tangcharoen, T., additional, Prasertkulchai, W., additional, Yamwong, S., additional, Sritara, P., additional, Binti Ngah, N., additional, Cruz, D., additional, Rebellato, L., additional, Daleffe, E., additional, Facchin, D., additional, Melao, F., additional, Paiva, M., additional, Pinho, T., additional, Martins, E., additional, Vasconcelos, M., additional, Madureira, A., additional, Macedo, F., additional, Ramos, I., additional, Maciel, M., additional, Agoston-Coldea, L., additional, Marjanovic, Z., additional, Hadj Khelifa, S., additional, Kachenoura, N., additional, Lupu, S., additional, Soulat, G., additional, Farge-Bancel, D., additional, Mousseaux, E., additional, Dastidar, A., additional, Augustine, D., additional, McAlindon, E., additional, Leite, S., additional, Sousa, C., additional, Rangel, I., additional, El ghannudi, S., additional, Lefoulon, A., additional, Noel, E., additional, Germain, P., additional, Doutreleau, S., additional, Jeung, M., additional, Gangi, A., additional, Roy, C., additional, Pisciella, L., additional, Zachara, E., additional, Federica, R., additional, Emdin, M., additional, Baydes, R., additional, Mahmoud, I., additional, and Jackson, T., additional

Published
2014
Full Text
View/download PDF

45. O3 ADDING PEGINTERFERON TO ENTECAVIR INCREASES RESPONSE RATES IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS: WEEK 96 RESULTS OF A GLOBAL MULTICENTER RANDOMISED TRIAL (ARES STUDY)

Author

Brouwer, W.P., primary, Xie, Q., additional, Sonneveld, M.J., additional, Zhang, N.P., additional, Zhang, Q., additional, Tabak, F., additional, Streinu, A., additional, Wang, J.-Y., additional, Idilman, R., additional, Reesink, H.W., additional, Diculescu, M., additional, Simon, K., additional, Voiculescu, M., additional, Akdogan, M., additional, Mazur, W., additional, Reijnders, J.G.P., additional, Verhey, E., additional, Hansen, B.E., additional, and Janssen, H.L.A., additional

Published
2014
Full Text
View/download PDF

46. Phytoestrogens and Prostate Disease

Author

Adlercreutz, H., Mazur, W., Bartels, P., Elomaa, V.-V., Watanabe, S., Wähälä, K., Landström, M., Lundin, E., Bergh, A., Damber, J.-E., Åman, P., Widmark, A., Johansson, A., Zhang, J.-X., and Hallmans, G.

Published
2000
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results